Saudi Arabia, India & Indonesia16 Apr 2020 10:02
‘Novacyt has also received emergency use approval for its test from the Federal Drug Agency of Saudi Arabia and from the National Agency of Drug and Food Control of the Republic of Indonesia, as well as import approval from the Drugs Controller General of India.’
This golden nugget was tucked right at the bottom of yesterday’s RNS and imho should’ve been in caps to shout it out to shareholders. This is amazing news and underlines the massive global sales strategy from NCYT - think of the numbers! These countries are weeks behind us and as tests get bought up around the world they will be desperate to make sure their populations are covered. Huge unimaginable numbers of population. ££££££’s
IMHO DYOR GLA